Milestone Scientific (NYSE:MLSS) shares rose today after the company said it won marketing clearance in Saudi Arabia, weeks after winning a regulatory nod in Australia for its epidural and intra-articular instruments.
The company’s CompuFlo Epidural instrument uses dynamic pressure sensing to help anesthesiologists correctly identify the epidural space and significantly reduce complications, according to Milestone. The CompuFlo Intra-Articular instrument also features dynamic pressure sensing for precise computerized drug injections into intra-articular joint spaces for patients with osteoarthritis.
Get the full story at our sister site, Drug Delivery Business News.
The post Milestone Scientific lands marketing clearance in Saudi Arabia, Australia appeared first on MassDevice.